Drugging MYCN through an Allosteric Transition in Aurora Kinase A.
Gustafson, W.C., Meyerowitz, J.G., Nekritz, E.A., Chen, J., Benes, C., Charron, E., Simonds, E.F., Seeger, R., Matthay, K.K., Hertz, N.T., Eilers, M., Shokat, K.M., Weiss, W.A.(2014) Cancer Cell 26: 414-427
- PubMed: 25175806 
- DOI: 10.1016/j.ccr.2014.07.015
- Primary Citation of Related Structures:  
4J8M, 4J8N - PubMed Abstract: 
MYC proteins are major drivers of cancer yet are considered undruggable because their DNA binding domains are composed of two extended alpha helices with no apparent surfaces for small-molecule binding. Proteolytic degradation of MYCN protein is regu ...